Showing results (291-300 of 322) with videos related to
Sort By:
Pageof 33
European Journal of Immunology|September 1, 1993
In vitro induction of human cytotoxic T lymphocyte responses against peptides of mutant and wild-type p53J G Houbiers, H W Nijman, S H van der Burg, et al.Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|May 20, 1998
An enzyme-linked immunosorbent assay for the measurement of circulating antibodies to polymorphic epithelial mucin (MUC1)S von Mensdorff-Pouilly, M M Gourevitch, P Kenemans, et al.Cancer Letters|June 3, 1997
Autoantibodies to p53 in ovarian cancer patients and healthy women: a comparison between whole p53 protein and 18-mer peptides for screening purposesC J Vennegoor, H W Nijman, J W Drijfhout, et al.Climacteric : the Journal of the International Menopause Society|December 5, 2009
Therapeutic options for postmenopausal female sexual dysfunctionF Al-Azzawi, J Bitzer, U Brandenburg, et al.Journal of Clinical Pathology|November 24, 1999
Accumulation of p53 protein is frequent in ovarian cancers associated with BRCA1 and BRCA2 germline mutationsR P Zweemer, P A Shaw, R M Verheijen, et al.Neuron|September 11, 2012
Attentional stimulus selection through selective synchronization between monkey visual areasConrado A Bosman, Jan-Mathijs Schoffelen, Nicolas Brunet, et al.European Journal of Cancer (Oxford, England : 1990)|May 29, 2007
Humoral immune responses to MUC1 in women with a BRCA1 or BRCA2 mutationB B J Hermsen, R H M Verheijen, F H Menko, et al.The American Journal of Tropical Medicine and Hygiene|February 6, 1998
Natural polymorphism in the thrombospondin-related adhesive protein of Plasmodium falciparumK J Robson, A Dolo, I R Hackford, et al.The Journal of Pathology|December 18, 2001
Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancerJ M Piek, P J van Diest, R P Zweemer, et al.Molecular and Cellular Endocrinology|July 14, 2001
Transforming growth factor beta signalling in vitro and in vivo: activin ligand-receptor interaction, Smad5 in vasculogenesis, and repression of target genes by the deltaEF1/ZEB-related SIP1 in the vertebrate embryoA Zwijsen, L A van Grunsven, E A Bosman, et al.Pageof 33